Skip to main content

Primary Osteoarthritis

0
Pipeline Programs
3
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Medacta
MedactaSwitzerland - Castel San Pietro
4 programs
Clinical and Radiological Outcomes of Medacta Shoulder System FRN/A1 trial
Medacta Shoulder SystemN/A1 trial
Medacta Shoulder SystemN/A1 trial
MiniMAXN/A1 trial
Active Trials
NCT05926622Recruiting200Est. Mar 2037
NCT03547947Active Not Recruiting200Est. Apr 2031
NCT05002335Active Not Recruiting200Est. Dec 2027
+1 more trials
Zimmer Biomet
Zimmer BiometFL - Jacksonville
2 programs
Avantage Reload cupN/A1 trial
Avenir® Cemented Hip Stem - PMCFN/A1 trial
Active Trials
NCT03357445Active Not Recruiting500Est. Apr 2027
NCT03396224Active Not Recruiting100Est. Nov 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
MedactaClinical and Radiological Outcomes of Medacta Shoulder System FR
MedactaMedacta Shoulder System
MedactaMiniMAX
MedactaMedacta Shoulder System
Zimmer BiometAvenir® Cemented Hip Stem - PMCF
Zimmer BiometAvantage Reload cup

Clinical Trials (6)

Total enrollment: 1,300 patients across 6 trials

NCT05926622MedactaClinical and Radiological Outcomes of Medacta Shoulder System FR

Clinical and Radiological Outcomes of Medacta Shoulder System FR

Start: Mar 2022Est. completion: Mar 2037200 patients
N/ARecruiting
NCT05002335MedactaMedacta Shoulder System

Clinical and Radiological Outcomes of Medacta Shoulder System (BE)

Start: Oct 2020Est. completion: Dec 2027200 patients
N/AActive Not Recruiting
NCT06012656MedactaMiniMAX

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

Start: Jan 2019Est. completion: Jan 2031100 patients
N/AActive Not Recruiting
NCT03547947MedactaMedacta Shoulder System

Clinical and Radiological Outcomes of Medacta Shoulder System

Start: Jun 2018Est. completion: Apr 2031200 patients
N/AActive Not Recruiting
NCT03396224Zimmer BiometAvenir® Cemented Hip Stem - PMCF

Avenir® Cemented Hip Stem - PMCF

Start: Nov 2015Est. completion: Nov 2030100 patients
N/AActive Not Recruiting
NCT03357445Zimmer BiometAvantage Reload cup

AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study

Start: Oct 2011Est. completion: Apr 2027500 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,300 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.